fbpx

Good news! At DC Derm Docs, we are soon able to offer what is being called the new Botox- Daxi!

What Is Daxi?

Daxi is the latest neuromodulator on the market that works to target the muscles beneath your skin to release the tension which causes wrinkles to form.

However, although Daxi shares the same primary active ingredient as Botox it also contains a proprietary peptide excipient to stabilize the solution.

The Competing Brands

For years Botox has been regarded as the gold standard when it comes to eliminating the signs of aging on your face.

Over time there have been other competing brands introduced to the market which have also been found to be effective at removing wrinkles from between the brows.

These products include Dysport, Xeomin and Jeuveau.

However, while each of these products have been found to be effective by the FDA, none have really set themselves apart against Botox for patients looking for long term results.

Until now.

The Daxi Difference

Daxi has established itself as the latest neuromodulator product to far surpass the result timeframe of all of the competing brands including Botox.

In fact, early clinical studies have shown the wrinkle reducing results to last an average of 24 weeks for injected patients.

This is staggering when considering the 13-17-week average from Botox, Dysport, Xeomin and Jeuveau.

That means you would only need to undergo TWO injectable treatments with Daxi in one year to maintain your results.

Impressive Results

In addition to proving a longer lasting alternative to Botox injections, Daxi has boasted a 95 percent response rate in clinical trials which is being lauded as the “largest aesthetic neuromodulator clinical trial” ever done.

Understandably, doctor and patients are excited about this new product and are looking forward to it hitting the market pending widespread FDA approval over the next few months.

To learn more about Daxi at DC Derm Docs, please call us today to schedule an appointment with one of our expert injectors at (202) 822-9591.

Leave a comment